Symmetry Partners, LLC has released its latest 13F-HR filing, revealing a total of approximately $1.96 billion in assets as of September 30, 2026. This filing is significant as it showcases the firm's investment strategy and highlights its positions in major companies, reflecting its focus on sectors poised for growth.

The firm, based in Glastonbury, Connecticut, operates within the investment management industry, providing services that include asset management and advisory. The latest filing, accession number 0001697493-26-000006, was submitted to the SEC on October 27, 2026. This is part of a series of filings that Symmetry Partners has made throughout the year, demonstrating its active engagement in managing a diverse portfolio.

According to the filing, Symmetry Partners holds significant stakes in several well-known companies. Notable investments include:

  • **Apple Inc.** - $28,697,018
  • **Amazon.com Inc.** - $4,252,479
  • **Alphabet Inc.** - $3,229,520 (Class A and Class C shares)
  • **Advanced Micro Devices Inc.** - $1,119,696
  • **AbbVie Inc.** - $808,199

The filing indicates that Symmetry Partners is particularly focused on technology and healthcare sectors, which are critical for growth in the current market environment. These sectors have shown resilience and potential for high returns, making them attractive for investment managers.

This update may have implications for other firms in the investment management industry, as they may need to reassess their strategies in light of Symmetry's significant asset allocation. Competitors may look to adjust their portfolios to better align with market trends highlighted by Symmetry's investments.

Looking ahead, the filing does not specify what actions Symmetry Partners will take next, but the continued focus on technology and healthcare suggests that the firm will maintain its current strategy of investing in high-growth sectors.

In summary, Symmetry Partners' latest 13F-HR filing underscores its robust investment strategy, with a significant focus on major players in the technology and healthcare sectors. This positions the firm well within the competitive landscape of the investment management industry.